First Wilshire Securities Management’s PAVmed PAVM Stock Holding History

First Wilshire Securities Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-222	Closed	-$29K	–	86
2023 Q3	$29K	Hold	222	–	–	0.01%	84
2023 Q2	$41K	Hold	222	–	–	0.01%	84
2023 Q1	$37K	Hold	222	–	–	0.01%	84
2022 Q4	$48K	Hold	222	–	–	0.02%	84
2022 Q3	$86K	Hold	222	–	–	0.03%	81
2022 Q2	$93K	Hold	222	–	–	0.03%	83
2022 Q1	$132K	Hold	222	–	–	0.05%	86
2021 Q4	$246K	Hold	222	–	–	0.08%	79
2021 Q3	$854K	Hold	222	–	–	0.28%	32
2021 Q2	$640K	Hold	222	–	–	0.22%	37
2021 Q1	$444K	Hold	222	–	–	0.17%	52
2020 Q4	$212K	Buy	222 +111	+100%	+$94.9K	0.09%	75
2020 Q3	$89K	Buy	+111	New	+$98.8K	0.04%	72

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

First Wilshire Securities Management's PAVM Position: Q4 2023 in Review

First Wilshire Securities Management sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 222 shares — an estimated $29K sold.

First Wilshire Securities Management first reported a position in PAVM in Q3 2020 and held it in 13 quarters. The position peaked at $854K in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

First Wilshire Securities Management reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
First Wilshire Securities Management sold 222 PAVmed shares in Q4 2023, an estimated $29K.
First Wilshire Securities Management first reported a position in PAVmed in Q3 2020 and held it in 13 quarters.
First Wilshire Securities Management's PAVmed position peaked at $854K in Q3 2021.
23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on First Wilshire Securities Management's 13F filing for Q4 2023, filed 12 Feb 2024.